The epidemiology and clinical manifestations of human immunodeficiency virus-associated tuberculosis in Hong kong

Hong Kong Medical Journal

Volumn 16, Issue 3, 2010, Pages 192-198

  Chan, C K ^a   Alvarez Bognar, F ^a   Wong, K H ^a   Leung, C C ^a   Tam, C M ^a   Chan, Kenny C W ^a   Ho, C F ^a   Chan, W K ^a   Mak, Ida K Y ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

Aids related opportunistic infections; Anti HIV agents; HIV infections; Multidrug resistant; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DELAYED DIAGNOSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE REGISTRY; FEMALE; HEALTH CARE POLICY; HEALTH PROGRAM; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT REFERRAL; PNEUMOCYSTIS PNEUMONIA; RETROSPECTIVE STUDY; TUBERCULOSIS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; MIDDLE AGED; REGISTER; TUBERCULOSIS, MULTIDRUG-RESISTANT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 77955808121     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Global tuberculosis control 2008: surveillance, planning, financing. World Health Organization website: http://www.who.int/tb/publications/global_report/2008/pdf/fullreport.pdf. Accessed 23 Jun 2008.
2. El-Sadr WM, Tsiouris SJ. HIV-associated tuberculosis: diagnostic and treatment challenges. Semin Respir Crit Care Med 2008;29:525-31.
3. AIDS epidemic update: December 2007. Geneva: UNAIDS.
4. Tuberculosis and HIV: a framework to address TB-HIV co-infection in the Western Pacific Region, 2004. Manila: World Health Organization Regional Office for the Western Pacific.
5. Tuberculosis and HIV: a revised framework to address TB-HIV co-infection in the Western Pacific Region, 2008. Manila: World Health Organization Regional Office for the Western Pacific.
6. Varma JK, Wiriyakitjar D, Nateniyom S, et al. Evaluating the potential impact of the new Global Plan to Stop TB: Thailand, 2004-2005. Bull World Health Organ 2007;85:586-92.
7. Cain KP, Kanara N, Laserson KF, et al. The epidemiology of HIV-associated tuberculosis in rural Cambodia. Int J Tuberc Lung Dis 2007;11:1008-13.
8. Trinh TT, Shah NS, Mai HA, et al. HIV-associated TB in An Giang Province, Vietnam, 2001-2004: epidemiology and TB treatment outcomes. PloS One 2007;2:e507.
9. Annual Report 2006. Hong Kong; Tuberculosis and Chest Service, Department of Health.
10. HIV Surveillance Report 2007 Update. Hong Kong; Special Preventive Programme, Department of Health.
11. Guidelines for HIV surveillance among tuberculosis patients. 2nd ed. Geneva: WHO; 2004.
12. Scientific Committee on AIDS. Classification system for HIV infection and surveillance case definition for AIDS in adolescents and adults in Hong Kong. Hong Kong Advisory Council on AIDS; 1995.
13. Grabar S, Lanoy E, Allavena C, et al. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy. HIV Med 2008;9:246-56.
14. Staehelin C, Rickenbach M, Low N, et al. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival. AIDS 2003;17:2237-44.
15. Sabin C, Monforte AD, May M, et al. The changing incidence of clinical AIDS events in 12,574 treatment-naive patients starting HAART. 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, CA, February 2007 [Abstract 569].
16. Combating HIV/AIDS and tuberculosis. WPR/RC58/7 June 27, 2007. Manila, World Health Organization Regional Office for the Western Pacific.
17. Hanson DL, Chu SY, Farizo KM, Ward JW. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group. Arch Intern Med 1995;155:1537-42.
18. Girardi E, Palmieri F, Cingolani A, et al. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001;26:326-31.
19. Aaron L, Saadoun D, Calatroni I, et al. Tuberculosis in HIVinfected patients: a comprehensive review. Clin Microbiol Infect 2004;10:388-98.
20. Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993;148:1292-7.
21. Lee MP, Chan JW, Ng KK, Li PC. Clinical manifestations of tuberculosis in HIV-infected patients. Respirology 2000;5:423-6.
22. Smith RL, Yew K, Berkowitz KA, Aranda CP. Factors affecting the yield of acid-fast sputum smears in patients with HIV and tuberculosis. Chest 1994;106:684-6.
23. Klein NC, Duncanson FP, Lenox TH 3rd, Pitta A, Cohen SC, Wormser GP. Use of mycobacterial smears in diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest 1989;95:1190-2.
24. Long R, Scalcini M, Manfreda J, Jean-Baptiste M, Hershfield E. The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis. Am J Public Health 1991;81:1326-8.
25. Hull MW, Phillips P, Montaner JS. Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest 2008;134:1287-98.
26. Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007;196(Suppl 1):86S-107S.
27. Anti-tuberculosis drug resistance in the world. Report No. 4. Geneva: WHO; 2008.